Skandinaviska Enskilda Banken (SEB)’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-43,600
Closed -$1.42M 828
2023
Q4
$1.42M Hold
43,600
0.01% 643
2023
Q3
$1.19M Sell
43,600
-9,000
-17% -$245K 0.01% 652
2023
Q2
$1.17M Sell
52,600
-53,500
-50% -$1.19M 0.01% 677
2023
Q1
$2.3M Buy
+106,100
New +$2.3M 0.02% 519
2021
Q2
Sell
-22,800
Closed -$542K 1059
2021
Q1
$542K Sell
22,800
-3,900
-15% -$92.7K ﹤0.01% 918
2020
Q4
$698K Sell
26,700
-77,200
-74% -$2.02M ﹤0.01% 869
2020
Q3
$1.81M Buy
103,900
+32,200
+45% +$560K 0.01% 594
2020
Q2
$1.21M Buy
+71,700
New +$1.21M 0.01% 688